RQ Bio
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
$115MSeries A
Role not disclosedL
LifeArc
Activity from announced rounds
Activity in this selectionvarsity-healthcare-partners-b0f02dbc
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $174.8M 2 disclosed · full round size, not this investor’s share